Profile

Nemesis Bioscience

Nemesis Bioscience was founded in 2014 to address the global threat posed by increasing bacterial resistance to commonly used antibiotics.

Nemesis will commercialise inventions to make existing antibiotics effective once more by not only overcoming resistant bacterial infections but also by preventing them in susceptible patients.

Status current

Associated Fund UK Innovation & Science Seed Fund

Sector Medical / Biotechnology

Website www.nemesisbio.com

Associated Team Members

Relevant News

Nemesis Bioscience Closes Funding Round And Begins Preclinical Programmes

Nemesis Bioscience today announced the successful completion of its latest funding round, bringing total seed…

read more

SHIONOGI INVESTS IN NEMESIS TECHNOLOGY

PHOTO:  From Left: Prof Conrad Lichtenstein (Nemesis CSO), Dr Frank Massam (Nemesis CEO), Dr...

read more

Nemesis Bioscience Appoints Dr Mark McCamish As Scientific Advisor

Nemesis Bioscience today announced the appointment of Dr Mark McCamish as Scientific Advisor for...

read more

Nemesis Bioscience Closes Funding Round And Begins Preclinical Programmes

Nemesis Bioscience today announced the successful completion of its latest funding round, bringing total...

read more

More Companies in Medical / Biotechnology